GlassScriptPhysician profile
Mary Riley
NPI 1568848299
$646.89
in general payments reported to CMS, 2019-2025
17 companies · $315 in 2025
The $315 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $25.72 · 2024: $306 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $621.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $157.91 | 2024-2025 | Keytruda, Lynparza, Welireg |
| Novartis Pharmaceuticals Corporation | $148.20 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $54.09 | 2024-2025 | Iclusig, Ninlaro |
| Pharmacyclics LLC, An Abbvie Company | $25.72 | 2022 | |
| Myriad Genetic Laboratories, INC. | $25.59 | 2025 | Myrisk |
| Karyopharm Therapeutics INC. | $23.73 | 2025 | Xpovio |
| Daiichi Sankyo INC. | $23.41 | 2024 | Enhertu |
| Incyte Corporation | $22.42 | 2025 | Monjuvi |
| Lilly USA, LLC | $20.98 | 2025 | Verzenio, Jaypirca |
| Stemline Therapeutics INC. | $19.93 | 2024 | Orserdu |
| Emd Serono, INC. | $19.65 | 2024 | |
| Abbvie INC. | $19.33 | 2024 | |
| Pfizer INC. | $18.98 | 2024 | |
| Aveo Pharmaceuticals, INC. | $17.85 | 2025 | |
| Exelixis INC. | $17.55 | 2024 | Cabometyx |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $17.00 | 2024 | Enhertu |
| Novocure INC. | $14.55 | 2025 | Optune Lua (Novottf-200t) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Riley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.